Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 49,818 |
|
|||||
| News | - | ||||||
| Day High | 2.40 | Low High |
|||||
| Day Low | 2.2816 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Eledon Pharmaceuticals Inc | ELDN | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.0901 | 3.92% | 2.3901 | 10:18:31 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2.38 | 2.2816 | 2.40 | 2.30 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 236 | 49,818 | US$ 2.37 | US$ 118,021 | - | 1.07 - 2.95 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 10:18:31 | 7 | US$ 2.40 | USD |
Eledon Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 56.14M | 24.20M | - | 0 | -40.33M | -1.67 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Eledon Pharmaceuticals News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ELDN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.05 | 2.43 | 2.00 | 2.31 | 151,740 | 0.3401 | 16.59% |
| 1 Month | 1.76 | 2.43 | 1.52 | 2.02 | 134,062 | 0.6301 | 35.80% |
| 3 Months | 1.70 | 2.43 | 1.5199 | 1.93 | 101,679 | 0.6901 | 40.59% |
| 6 Months | 1.33 | 2.43 | 1.07 | 1.76 | 87,598 | 1.06 | 79.71% |
| 1 Year | 2.32 | 2.95 | 1.07 | 1.82 | 105,953 | 0.0701 | 3.02% |
| 3 Years | 10.12 | 10.20 | 1.07 | 3.18 | 72,870 | -7.73 | -76.38% |
| 5 Years | 15.80 | 22.91 | 1.07 | 4.17 | 71,973 | -13.41 | -84.87% |
Eledon Pharmaceuticals Description
| Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's lead compound in development is AT-1501 which is the next generation anti-CD40L antibody. |
